RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
  • RAPS' LatestRAPS' Latest

    7 Things Attendees Love About the Regulatory Convergence

    RAPS’ signature annual event, the Regulatory Convergence , is a unique opportunity for the regulatory community to gather, reconnect, examine important issues together and exchange ideas face-to-face in a setting completely dedicated to the profession. It is the largest annual conference anywhere in the world for regulatory professionals working in the healthcare product space. For many, it is the one event they prioritize above all others to attend each year. This year...
  • RAPS' LatestRAPS' Latest

    10 Ways to Get the Most From RAPS' Regulatory Convergence

    Your time is valuable. We respect and appreciate the time you take to attend the  Regulatory Convergence , and we want you to get as much out of RAPS’ signature annual event as you can. After all, it is an investment in your job, your career and your regulatory knowledge. And for those of you who may be first-time attendees, it can be particularly helpful to have an idea of what to expect. So we have a few tips to help you make the most of your Convergence experience this...
  • RAPS' LatestRAPS' Latest

    RAPS Members on the Value of Regulatory Convergence

    RAPS’ Regulatory Convergence is the world’s largest annual gathering for the healthcare product regulatory profession, and this year will be held 17–20 September in San Jose, CA. Speakers and attendees come from all over the world to learn, network and exchange ideas. We recently asked a number of RAPS members at various stages of their regulatory careers about the value of attending the Convergence, and here’s what they had to say: “Regulatory Convergence is...
  • RAPS' LatestRAPS' Latest

    Bay Area Regulatory Pros Looking Forward to Convergence's Return to San Jose

    The Regulatory Convergence will return to San Jose, CA, in 2016, bringing RAPS’ signature annual event back not only to one of the world’s premier centers of technology and innovation—Silicon Valley—but also to the home of RAPS’ oldest and one of its most active chapters, the San Francisco Bay Area Chapter. RAPS asked some of the local chapter’s volunteers and other local regulatory professionals about what makes the San Francisco Bay Area such a special place, an...
  • RAPS' LatestRAPS' Latest

    A Global Regulatory Gathering in FDA's Backyard

    If you look at the conference agenda for RAPS’ Regulatory Convergence taking place next month, you might notice some recurring themes. The importance of regulatory strategy, the intersection of regulatory and business and the need to build regulatory capacity and competence will be discussed and thoroughly examined during the Convergence. With more than 100 sessions and more than 300 speakers, the Convergence promises to cover a wide range of re...
  • RAPS' LatestRAPS' Latest

    Regulatory Experts Urge Caution With Communications Activities

    The Office of Prescription Drug Promotion (OPDP) and its Advertising and Promotional Labeling Branch (APLB) of the US Food and Drug Administration (FDA) have been busy. Over the past year, they have released multiple guidances, expanded the so-called "bad ad" program that asks healthcare professionals to police inappropriate promotional efforts, and issued a number of untitled and Warning Letters. During a panel discussion at 2012 RAPS: The Regulatory Convergence , regu...
  • RAPS' LatestRAPS' Latest

    Experts Examine Regulation of Health-Related Mobile Apps, Software and Social Media

    When it comes to the regulation of mobile apps, software and social media in the healthcare space, intent is key but absolute clarity is elusive, according to the expert presenters who spoke to attendees during a session at 2012 RAPS: The Regulatory Convergence in Seattle. The speakers, Center for Medicine in the Public Interest Founder Peter Pitts; Head of Emerging Technologies, Devices Division for the UK's Medicines and Healthcare products Regulatory Agency (MHRA) Ne...
  • RAPS' LatestRAPS' Latest

    Regulatory Professionals, Top Regulators From Around the World to Converge in Seattle for 2012 RAPS

    In a few weeks, 2012 RAPS: The Regulatory Convergence will bring approximately 70 healthcare regulators and some 2,000 total attendees from around the world to Seattle. The regulatory officials scheduled to speak represent national and international agencies overseeing health products, including 36 speakers from the US Food and Drug Administration (FDA), as well as representatives from agencies in Europe, China, Japan, India, Brazil, Canada and more. The Regulatory Conv...